IntelGenx Technologies Corp. (OTCMKTS:IGXT) will release its earnings data after the market closes on Thursday, November 9th. Analysts expect IntelGenx Technologies Corp. to post earnings of ($0.01) per share for the quarter.

COPYRIGHT VIOLATION WARNING: This story was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at

Separately, ValuEngine downgraded shares of IntelGenx Technologies Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, August 22nd.

About IntelGenx Technologies Corp.

IntelGenx Technologies Corp. is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets.

Receive News & Ratings for IntelGenx Technologies Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies Corp. and related companies with's FREE daily email newsletter.